Nuvasive Overview
Nuvasive Target Price
Analysts' 12-month price predictions for NUVA.
Get informed when a big investor buys or sells
+ FollowShare Price
$39.75
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2022-11-10 | RBC Capital | $58 |  45.9% upside |  |
| 2022-08-23 | Piper SandlerMatt O'Brien | $60 | 50.9% upside | |
| 2021-12-21 | Truist FinancialDavid Rescott | $60 | 50.9% upside | |
| 2021-12-17 | J.P. MorganAllen Gong | $50 | 25.8% upside | |
| 2021-12-15 | CitigroupJoanne Wuensch | $64 | 61% upside | |
| 2021-11-15 | Piper SandlerMatthew O'Brien | $80 | 101.3% upside | |
| 2021-11-10 | Canaccord GenuityKyle Rose | $60 | 50.9% upside | |
| 2021-11-10 | UBSMatthew Taylor | $54 | 35.8% upside | |